More than ten percent of relapses occur after five years in AML patients with NPM1 mutation. Issue 5 (15th April 2020) - Bertoli, Sarah; Tavitian, Suzanne; Bérard, Emilie; Mansat-De Mas, Véronique; Largeaud, Laetitia; Gadaud, Noémie; Rieu, Jean-Baptiste; Vergez, François; Luquet, Isabelle; Huguet, Françoise; Sarry, Audrey; Delabesse, Eric; et al.